SCHEMBL6537435

SCHEMBL6537435

CCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1CC(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 2/20 0.40
JAK2 O60674 5/20 0.39
JAK1 P23458 5/20 0.39
TYK2 P29597 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CRHBP P24387 1/20 0.39
HTT P42858 1/20 0.39
CRHR2 Q13324 1/20 0.39
SLC16A3 O15427 1/20 0.38
ABL1 P00519 1/20 0.37
SRC P12931 1/20 0.37
PDCD1 Q15116 2/20 0.37
CD274 Q9NZQ7 2/20 0.37
PDE10A Q9Y233 1/20 0.37
GAA P10253 1/20 0.37
PTGES O14684 1/20 0.37
HDAC3 O15379 1/20 0.36
NCOR1 O75376 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537581 0.90 SLC16A3 (0.42) MEN1KMT2AJAK2JAK1TYK2
SCHEMBL6537856 0.88 TYK2 (0.40) MEN1KMT2APOLBJAK2JAK1
SCHEMBL6538164 0.88 PTGES (0.43) MEN1KMT2APOLBJAK2JAK1
SCHEMBL6537711 0.87 TYK2 (0.42) MEN1KMT2APOLBJAK2JAK1
SCHEMBL6537622 0.87 TYK2 (0.42) MEN1KMT2APOLBJAK2JAK1
SCHEMBL6538125 0.85 SLC16A3 (0.41) MEN1KMT2APOLBJAK2JAK1
SCHEMBL6537864 0.84 POLB (0.45) MEN1KMT2APOLBJAK2JAK1
SCHEMBL6537806 0.84 JAK2 (0.40) MEN1KMT2APOLBJAK2JAK1
SCHEMBL6537689 0.84 SLC16A3 (0.40) MEN1KMT2APOLBJAK2JAK1
SCHEMBL6538180 0.84 DGAT2 (0.44) MEN1KMT2APOLBJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed